Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capsid protein VP1 is the major structural protein found in the capsids of several viruses, most notably polyomaviruses, adeno-associated viruses (AAVs), and parvoviruses. It plays a central role in viral assembly, host cell recognition, and infection initiation. VP1 monomers are typically around 350 amino acids long and form pentamers that assemble into the outer shell of the capsid. VP1 initiates infection by binding to sialic acids on host cell surfaces, leading to entry via endocytosis. It also possesses NLS motifs essential for nuclear import during virion assembly. It can self-assemble into VLPs making it useful for vaccine development. In some viruses it may have a unique N-terminal extension with phospholipase activity.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsid Protein VP1 (VP1).